Navneet Kaur*
Department of Periodontology & Oral Implantology, National Dental College and Hospital
*Correspondence: Navneet Kaur, Associate Professor, Department of Periodontology & Oral Implantology,National Dental College and Hospital, Derabassi, Punjab, India. Email: kaurparneet1963@gmail.com
Received: 27 Nov, 2025; Accepted: 22 Dec, 2025; Published: 04 Jan, 2026.
Citation: Navneet Kaur. “Modern Bone Grafts: Redefining Periodontal Regeneration.” J Oral Dis Treat (2026):112. DOI: 10.59462/JODT.3.1.112
Copyright: ©© 2025 Navneet Kaur. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribu tion, and reproduction in any medium, provided the original author and source are credited.
Abstract
Bone grafts are frequently used in orthopaedics, Periodontics, and in oral and maxillofacial surgery with effective clinical outcomes. This approach has been used routinely as a treatment for bone regeneration in osseous defects. Although the greatest success in bone grafting has been achieved with autogenous bone, such use is constrained by limited material supply and donor site morbidity. Numerous biomaterials have been successfully used as bone substitutes, such as allograft, xenografts, natural and synthetic calcium-based materials, and a combination of these. Although current approaches to bone regeneration generally provide satisfactory outcomes, they remain limited by certain drawbacks, availability issues, and conflicting evidence regarding their efficacy and cost-effectiveness. Even heterologous or synthetic substitutes currently do not possess biological or mechanical characteristics which must be at an equal level in comparison with natural bone. Consequently, there is a continuing need to develop innovative therapies, either as alternatives or as adjuncts to conventional techniques, to address these limitations-a challenge that has been pursued for several decades.
Keywords: Regeneration; Bone Grafts; Platelet Rich Plasma; Growth Factors; Osteogenesis;Scaffolds
Introduction
Bone regeneration is complicated controlled physiological method to form a new type of bone similar with the process of fracture healing and remodelled continuously throughout adult life. Moreover, in complicated clinical situations where more amount of bone regeneration is needed like for skeletal reconstruction, in case of large bony defects caused by trauma, infection, tumour resection and skeletal abnormalities, or in cases where regeneration step is very compromised including avascular necrosis, atrophic non-unions and osteoporosis.
At present, numerous strategies are employed to enhance compromised or inadequate bone regeneration. These include the traditional “gold standard” autologous bone graft, vascularized free fibula grafts, allograft transplantation, as well as the application of growth factors, osteoconductive scaffolds, osteoprogenitor cells, and distraction osteogenesis. Advances in tissue engineering, gene therapy, and systemic approaches to bone repair are being actively explored to address the shortcomings of existing methods. The ultimate goal is to develop bone-graft substitutes that closely replicate the biomechanical properties of native bone, accelerate the regeneration process, and potentially offer therapeutic solutions for systemic conditions such as skeletal disorders and osteoporosis.
Current Clinical Approaches to Enhance Bone Regeneration
In cases where the natural process of bone regeneration is impaired or insufficient, surgeons have access to a range of therapeutic modalities. These interventions may be employed individually or in combination to address complex clinical situations that are often refractory to treatment, posing both medical and socioeconomic challenges. Widely adopted strategies to stimulate or augment bone regeneration include distraction osteogenesis, bone transport, [1] and several grafting techniques such as autologous bone grafts, allografts, and the application of bone-graft substitutes or growth factors. [2,3] An alternative approach for bone regeneration and reconstruction of extensive long-bone defects is the two-stage induced membrane technique (Masquelet Procedure). This method involves initial Placement of a Polymethylmethacrylate (PMMA) spacer to induce a vascularized membrane, followed in a second stage by removal of the spacer and insertion of cancellous bone graft within the biologically active chamber. [4] The induced membrane provides a favorable microenvironment for bone regeneration, thereby improving the chances of successful reconstruction in challenging cases. There are even non-invasive methods of biophysical stimulation, such as LowIntensity Pulsed Ultrasound (LIPUS) and pulsed electromagnetic fields (PEMF) [5,6] which are used as adjuncts to enhance bone regeneration.
Distraction Osteogenesis
Distraction osteogenesis is a well-established technique employed by orthopedic surgeons to repair long-bone defects without the need for grafting materials. Over the past 15 years, it has also gained widespread acceptance for the correction of various craniofacial deformities. The principle of the technique relies on inducing new bone formation between gradually separated osseous surfaces during distraction and bone transport. A range of devices are currently utilized to manage bone loss, limb-length discrepancies, and deformities, including external fixators, the Ilizarov apparatus,[1] combination of unreamed intramedullary nails with external monorail distraction systems,[7] and intramedullary lengthening devices [8].Despite its effectiveness, distraction osteogenesis is technically demanding and associated with several limitations, such as complications during treatment, prolonged treatment duration-both for distraction (approximately 1 mm/day) and for consolidation (typically twice the distraction period)-and negative impacts on patient psychology and overall well-being. [1]
Experimental studies in various animal models have demonstrated the successful application of distraction osteogenesis at multiple anatomical sites, including the mandible, maxilla, midface, and cranial vault. The technique offers several advantages over conventional osteotomy: it reduces operative time and intraoperative blood loss, eliminates the need for bone grafting, and promotes simultaneous adaptation of the surrounding soft tissues and nerves. Nonetheless, disadvantages remain, including the high technical sensitivity of the procedure, dependence on specialized equipment, the potential need for secondary surgery to remove distraction devices, and the necessity for strict patient compliance.
Bone Grafts and Artificial Bone Materials
Bone grafting is a widely practiced surgical technique to enhance bone regeneration in various oral and maxillofacial procedures. Among available grafting options, autologous bone remains the “gold standard,” as it uniquely combines all three essential properties of an ideal graft material: osteoinduction (include BMPs and growth factors), osteogenesis (production of osteoprogenitor cells), and osteoconduction (act as natural scaffold). Depending on clinical requirements, autologous bone may be harvested as a tricortical graft for structural support or as a vascularized graft for reconstruction of extensive defects or cases of avascular necrosis.
Traditional donor sites include the anterior and posterior iliac crests, though alternative harvesting techniques have recently emerged. For instance, the reamer–irrigator–aspirator (RIA) system, originally developed to minimize complications during longbone fracture management, allows the intramedullary canal of long bones to serve as a source of large volumes of autologous bone graft. [9] Importantly, since autologous bone originates from the patient, it is fully histocompatible and non-immunogenic, thereby minimizing risks of immune reactions or disease transmission. However, its use requires an additional surgical procedure, with associated morbidity, limited availability of graft volume, and significant costs.
Allogeneic Bone
As an alternative, allogeneic bone grafts-harvested from cadaveric or living human donors-avoid the limitations of autologous bone harvesting. These grafts are available in multiple preparations, such as demineralized bone matrix (DBM), morselized or cancellous chips, corticocancellous and cortical grafts, and even osteochondral or whole-bone segments, depending on the clinical indication. Although these grafts circumvent donor-site morbidity and availability issues, they lack viable cellular components and generally exhibit reduced osteoinductive potential due to devitalization during processing (e.g., irradiation or freeze-drying). Additional drawbacks include risks of immunogenicity, graft rejection, infection transmission, and higher costs.
Bone-Graft Substitutes
To overcome the shortcomings of autologous and allogeneic grafts, a wide variety of synthetic and natural bone substitutes have been developed. These materials act as scaffolds that support the migration, proliferation, and differentiation of bone cells, thereby facilitating regeneration. Commonly used biomaterials include collagen, hydroxyapatite (HA), β-tricalcium phosphate (β-TCP), calciumphosphate cements, and bioactive glass ceramics. Research in this area continues to evolve, particularly in developing substitutes capable of reconstructing large bone defects. In such cases, metallic or titanium mesh cages may be used as structural scaffolds, often combined with cancellous allograft, DBM, or autologous bone to achieve mechanical stability and promote osteogenesis.
Guided Bone Regeneration (GBR)
Guided bone regeneration (GBR) is another important technique that promotes new bone formation, particularly in the maxillofacial region. It is often used in conjunction with guided tissue regeneration (GTR), which facilitates concurrent soft-tissue reconstruction. GBR works by excluding epithelial and connective tissue from the defect site, thereby creating a protected space that allows periodontal ligament and bone cells to repopulate and regenerate the area. This method is frequently combined with bone grafts or platelet-rich plasma (PRP) to enhance outcomes. While GBR supports natural bone regeneration, a major drawback is the extended time required to achieve sufficient bone volume [10].
Platelet-Rich Plasma (PRP)
In dental and maxillofacial surgery, platelet-rich plasma (PRP) has been applied in multiple clinical contexts, including sinus floor elevation, alveolar ridge augmentation, mandibular reconstruction, maxillary cleft repair, treatment of periodontal defects, and preservation of extraction sockets. PRP is often used alone or in combination with autologous bone, anorganic bone minerals, or synthetic substitutes. Its therapeutic potential lies in the rich concentration of growth factors it delivers, such as platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), and basic fibroblast growth factor (bFGF). Additionally, blood proteins including fibrin, fibronectin, and vitronectin function as adhesion molecules, further supporting osteoconduction [11]. Collectively, these components influence bone healing and regeneration through multiple biological pathways.
Limitations of Current Strategies to Enhance Bone Regeneration
Most current approaches to bone regeneration achieve reasonably satisfactory outcomes; however, they are limited by issues of availability, cost-effectiveness, and inconsistent clinical efficacy. Importantly, no heterologous or synthetic substitute currently matches, the biological and mechanical properties of native bone. This underscores the continuing need for novel therapeutic strategies, either as alternatives or as adjuncts to conventional methods-a pursuit that has been ongoing for decades.
As early as the 1950s, Professor Sir John Charnley, a pioneering British orthopedic surgeon, remarked that “practically all classical operations of surgery have now been explored, and unless some revolutionary discovery is made which will put the control of osteogenesis in the surgeon’s power, no great advance is likely to come from modification of their detail.” Since that time, remarkable progress has been made in understanding bone regeneration at the cellular and molecular levels, and research continues to expand in this field.
Technological innovations such as quantitative three-dimensional microcomputed tomography, finite element modeling, and nanotechnology have enabled precise evaluation of the mechanical properties of regenerating bone at the microscopic scale. Parallel advances in cell and molecular biology have facilitated detailed histological analyses, characterization of bone-forming cells in vitro and in vivo, identification of transcriptional and translational profiles of key genes and proteins, and the creation of transgenic animal models to investigate the spatial and temporal expression of genes involved in bone repair.
These developments have fueled the exploration of novel therapeutic interventions, many of which are being integrated as adjuncts or alternatives to established regenerative techniques. Despite these advances, the fundamental principles guiding bone regeneration remain constant. Effective treatment must aim to satisfy the critical requirements for bone healing-namely osteoconductive scaffolds, osteoinductive signals, osteogenic cells, and mechanical stability-in line with the widely accepted “diamond concept” of fracture healing.
Conclusion
Significant progress has been made in understanding bone regeneration at the cellular and molecular levels, and this knowledge continues to expand. Recent developing techniques and tools have more potential to evaluate the mechnical properties at the molecular level. The cellular and molecular level is based on the histolofgical analysis to evaluate in vitro and in vivo characterization of bone-forming cells,identify the carrier genes and their proteins which are involved in bone regenration and fracture repair. Furthermore, the use of transgenic animal models has provided valuable insights into the roles of specific genes during bone healing, including their spatial and temporal patterns of expression.
Recent developments in biotechnology have expanded the range of available bone grafting materials, yet an ideal graft that perfectly replicates the properties of native bone has not been achieved. Current research efforts are therefore focused on the use of proteins and delivery carriers to enhance the local administration of growth factors at surgical sites. Although growth factors are present only in low concentrations within bone matrix and plasma, they play pivotal biological roles. By binding to transmembrane receptors on mammalian cells, they initiate intracellular signalling cascades that ultimately regulate transcriptional activity, leading to mRNA synthesis and subsequent intra- and extracellular protein release essential for bone regeneration.
References